Home LiteratureArticle Details
PMID: 16227431 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration.

Shi L, Sohaskey CD, Kana BD, Dawes S, North RJ, Mizrahi V, Gennaro ML

Abstract

Transcription profiling of genes encoding components of the respiratory chain and the ATP synthesizing apparatus of Mycobacterium tuberculosis was conducted in vivo in the infected mouse lung, and in vitro in bacterial cultures subjected to gradual oxygen depletion and to nitric oxide treatment. Transcript levels changed dramatically as infection progressed from bacterial exponential multiplication (acute infection) to cessation of bacterial growth (chronic infection) in response to host immunity. The proton-pumping type-I NADH dehydrogenase and the aa3-type cytochrome c oxidase were strongly down-regulated. Concurrently, the less energy-efficient cytochrome bd oxidase was transiently up-regulated. The nitrate transporter NarK2 was also up-regulated, indicative of increased nitrate respiration. The reduced efficiency of the respiratory chain was accompanied by decreased expression of ATP synthesis genes. Thus, adaptation of M. tuberculosis to host immunity involves three successive respiratory states leading to decreased energy production. Decreased bacterial counts in mice infected with a cydC mutant (defective in the cytochrome bd oxidase-associated transporter) at the transition to chronic infection provided initial evidence that the bd oxidase pathway is required for M. tuberculosis adaptation to host immunity. In vitro, NO treatment and hypoxia caused a switch from transcription of type I to type II NADH dehydrogenase. Moreover, cytochrome bd oxidase expression increased, but cytochrome c oxidase expression decreased slightly (nitric oxide) or not at all (hypoxia). These specific differences in respiratory metabolism during M. tuberculosis growth arrest in vitro and in vivo will guide manipulation of in vitro conditions to model bacterial adaptation to host immunity.

MeSH Terms
Adenosine Triphosphate/biosynthesis Aerobiosis Animals Cell Hypoxia Energy Metabolism Lung/microbiology Mice Mice, Inbred C57BL Mycobacterium tuberculosis/metabolism Nitric Oxide/pharmacology Oxygen Consumption Transcription, Genetic
Chemicals
Nitric Oxide Adenosine Triphosphate
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Shi Lanbo
Public Health Research Institute, Newark, NJ 07103, USA.
Sohaskey Charles D
Kana Bavesh D
Dawes Stephanie
North Robert J
Mizrahi Valerie
Gennaro Maria L
References (48)
48 references, click to expand
  1. Respiration metabolism reduces oxidative and acid stress to improve long-term survival of Lactococcus lactis.
    Mol Microbiol. 2004 Sep;53(5):1331-42 PMID: 15387813
  2. Membrane topology and mutational analysis of Escherichia coli CydDC, an ABC-type cysteine exporter required for cytochrome assembly.
    Microbiology. 2004 Oct;150(Pt 10):3415-27 PMID: 15470119
  3. Cytochrome bd biosynthesis in Bacillus subtilis: characterization of the cydABCD operon.
    J Bacteriol. 1998 Dec;180(24):6571-80 PMID: 9852001
  4. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.
    Tuberculosis (Edinb). 2004;84(3-4):218-27 PMID: 15207491
  5. Bacterial respiration: a flexible process for a changing environment.
    Microbiology. 2000 Mar;146 ( Pt 3):551-71 PMID: 10746759
  6. Immunology of tuberculosis.
    Annu Rev Immunol. 2001;19:93-129 PMID: 11244032
  7. Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis.
    Tuber Lung Dis. 2000;80(3):141-59 PMID: 10970762
  8. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.
    Nature. 1998 Jun 11;393(6685):537-44 PMID: 9634230
  9. Protein secretion by Gram-negative bacterial ABC exporters--a review.
    Gene. 1997 Jun 11;192(1):7-11 PMID: 9224868
  10. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action.
    J Biol Chem. 2004 Sep 17;279(38):40174-84 PMID: 15247240
  11. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
    Nature. 2000 Aug 17;406(6797):735-8 PMID: 10963599
  12. Control of the nitric oxide-cytochrome c oxidase signaling pathway under pathological and physiological conditions.
    IUBMB Life. 2003 Oct-Nov;55(10-11):585-90 PMID: 14711003
  13. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.
    Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7534-9 PMID: 11416222
  14. Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors.
    Biochim Biophys Acta. 1997 Jul 4;1320(3):217-34 PMID: 9230919
  15. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment.
    J Exp Med. 2003 Sep 1;198(5):693-704 PMID: 12953091
  16. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts.
    Br J Exp Pathol. 1961 Feb;42:83-8 PMID: 13740304
  17. Tuberculosis: a problem with persistence.
    Nat Rev Microbiol. 2003 Nov;1(2):97-105 PMID: 15035039
  18. Virulence of the tubercle bacillus. II. Effect of oxygen tension upon growth of virulent and avirulent bacilli.
    J Infect Dis. 1954 Jan-Feb;94(1):99-106 PMID: 13143228
  19. How oxygen is activated and reduced in respiration.
    Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):12971-3 PMID: 10557256
  20. Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis.
    J Bacteriol. 2001 Sep;183(18):5311-6 PMID: 11514514
  21. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.
    Infect Immun. 1996 Jun;64(6):2062-9 PMID: 8675308
  22. Nitric oxide and macrophage function.
    Annu Rev Immunol. 1997;15:323-50 PMID: 9143691
  23. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence.
    Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):241-6 PMID: 12506197
  24. Dormancy of Mycobacterium tuberculosis and latency of disease.
    Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):908-14 PMID: 7698116
  25. Immunity to tuberculosis.
    Annu Rev Immunol. 2004;22:599-623 PMID: 15032590
  26. Prokaryotic nitrate reduction: molecular properties and functional distinction among bacterial nitrate reductases.
    J Bacteriol. 1999 Nov;181(21):6573-84 PMID: 10542156
  27. Regulation of transcription at the ndh promoter of Escherichia coli by FNR and novel factors.
    Mol Microbiol. 1994 May;12(3):433-44 PMID: 8065261
  28. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice.
    Mol Microbiol. 2000 Mar;35(5):1017-25 PMID: 10712684
  29. Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis.
    J Biol Chem. 2004 May 28;279(22):23082-7 PMID: 15033981
  30. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice.
    Infect Immun. 1995 Sep;63(9):3428-37 PMID: 7642273
  31. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis.
    Cell Microbiol. 2003 Sep;5(9):637-48 PMID: 12925133
  32. Nonreplicating persistence of mycobacterium tuberculosis.
    Annu Rev Microbiol. 2001;55:139-63 PMID: 11544352
  33. Virulence of the tubercle bacillus. I. Effect of oxygen tension upon respiration of virulent and avirulent bacilli.
    J Infect Dis. 1954 Jan-Feb;94(1):90-8 PMID: 13143227
  34. Mycobacterial persistence: adaptation to a changing environment.
    Trends Microbiol. 2001 Dec;9(12):597-605 PMID: 11728873
  35. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program.
    J Exp Med. 2003 Sep 1;198(5):705-13 PMID: 12953092
  36. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro.
    J Bacteriol. 1956 Aug;72(2):132-41 PMID: 13366889
  37. Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis.
    J Bacteriol. 2001 Dec;183(24):7076-86 PMID: 11717265
  38. The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis.
    FEMS Microbiol Rev. 2000 Oct;24(4):449-67 PMID: 10978546
  39. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
    Science. 2005 Jan 14;307(5707):223-7 PMID: 15591164
  40. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice.
    J Exp Med. 2001 Feb 5;193(3):271-80 PMID: 11157048
  41. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice.
    Infect Immun. 2005 Jan;73(1):546-51 PMID: 15618194
  42. Persistent bacterial infections: the interface of the pathogen and the host immune system.
    Nat Rev Microbiol. 2004 Sep;2(9):747-65 PMID: 15372085
  43. Control of cytochrome c oxidase activity by nitric oxide.
    Biochim Biophys Acta. 2004 Apr 12;1655(1-3):365-71 PMID: 15100052
  44. Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis.
    J Bacteriol. 2003 Dec;185(24):7247-56 PMID: 14645286
  45. Redundancy of aerobic respiratory chains in bacteria? Routes, reasons and regulation.
    Adv Microb Physiol. 2000;43:165-224 PMID: 10907557
  46. Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis.
    Tuber Lung Dis. 1998;79(2):127-32 PMID: 10645451
  47. Purification of a cytochrome bc-aa3 supercomplex with quinol oxidase activity from Corynebacterium glutamicum. Identification of a fourth subunity of cytochrome aa3 oxidase and mutational analysis of diheme cytochrome c1.
    J Biol Chem. 2003 Feb 7;278(6):4339-46 PMID: 12446663
  48. Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs.
    Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4548-53 PMID: 15767566
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2005-10-25
Epub
2005-00-14
Pages
15629-34
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC1255738
Subset
IM
Grants
NIAID NIH HHS · R01 AI037844 · United States
NIAID NIH HHS · R21 AI059557 · United States
NIAID NIH HHS · AI 43420 · United States
NIAID NIH HHS · AI 37844 · United States
NIAID NIH HHS · AI 36989 · United States
NIAID NIH HHS · R01 AI036989 · United States
NIAID NIH HHS · AI 059557 · United States
NIAID NIH HHS · R01 AI043420 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com